Two of the three recently priced public companies have fallen below their share prices, demonstrating fears of the IPO market not being very friendly since the downfall of WeWork. Though the biotechnology sector is less sensitive to market volatility due to the specialized investor base, recent offerings from this sector have shown that even drug companies are starting to struggle in the current market environment.
Recently Priced:
The German biotechnology firm BioNTech SE
HBT Financial, Inc.
VIR Biotechnology, Inc.
Upcoming:
BellRing Brands, Inc., with 30 million shares, is set to price on the NYSE under the symbol BRBR on October 17 with a stock price between $16-$19. The firm has raised an offer amount of $655,500,000.
Innate Pharma SA is set to debut on the NASDAQ under the symbol IPHA on October 17. The stock is set to price between $7.50 with 10,666,666 shares. The firm has raised an offer amount of $91,999,987.50.
Filings:
89 Bio, Inc. filed with an offering amount of $70 million.
Azar International Corp filed with an offering of $150 thousand.
Centogene B.V. filed with an offering of $69 million.
Fangdd Network Group LTD. filed with an offering of $150 million.
Finserv Acquisition Corp. filed with an offering of $230 million.
Galera Therapeutics, Inc. filed with an offering of $86,250,000.
Finserv Acquisition Corp. filed with an offering of $230 million.
Merdia Merger Corp. I filed with an offering of $115 million.
Moving Image Technologies Inc. filed with an offering of $10,867,500.
Mtron Systems Acquisition Corp. filed with an offering of $143, 750, 000
Osprey Technology Acquisition Corp. filed with an offering of $287,500,000.
Q&K International Group LTD filed with an offering of $100 million.